Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balazs Halmos

Showing results (71-80 of 221) with videos related to

Pageof 23
Sort By:
International Journal of Radiation Oncology, Biology, Physics|August 10, 2019
Daily Step Counts: A New Prognostic Factor in Locally Advanced Non-Small Cell Lung Cancer?Nitin Ohri, Balazs Halmos, William R Bodner, et al.
Magnetic Resonance in Medicine|August 12, 2006
Three-dimensional magnetic resonance microscopy of pulmonary solitary tumors in transgenic miceShigeto Kubo, Elena Levantini, Susumu Kobayashi, et al.
Cancer Research|January 26, 2002
Down-regulation and antiproliferative role of C/EBPalpha in lung cancerBalazs Halmos, Claudia S Huettner, Olivier Kocher, et al.
The Oncologist|July 23, 2025
Datopotamab Deruxtecan-Associated Select Adverse Events: Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and ManagementAaron Lisberg, Laura A Huppert, Balazs Halmos, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2025
Randomized Evaluation of the PET-Adjusted IMRT for NSCLC Trial (REPAINT)Nitin Ohri, William R Bodner, Rafi Kabarriti, et al.
Investigational New Drugs|January 15, 2014
Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancerNeelesh Sharma, Nathan Pennell, Myles Nickolich, et al.
Clinical Lung Cancer|April 8, 2026
Impact of Consolidation Durvalumab on Local Control Following Chemoradiotherapy for Non-Small Cell Lung CancerAdel Zakharia, William Bodner, Balazs Halmos, et al.
The Oncologist|April 28, 2020
INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal MalignanciesKhvaramze Shaverdashvili, Elham Azimi-Nekoo, Perry Cohen, et al.
International Journal of Cancer|August 21, 2013
PIAS3 activates the intrinsic apoptotic pathway in non-small cell lung cancer cells independent of p53 statusSnehal Dabir, Amy Kluge, Karen McColl, et al.
Cancers|May 8, 2020
Impact and Diagnostic Gaps of Comprehensive Genomic Profiling in Real-World Clinical PracticeAditi P Singh, Elaine Shum, Lakshmi Rajdev, et al.
Pageof 23

Showing results (71-80 of 221) with videos related to

Sort By:
Pageof 23
International Journal of Radiation Oncology, Biology, Physics|August 10, 2019
Daily Step Counts: A New Prognostic Factor in Locally Advanced Non-Small Cell Lung Cancer?Nitin Ohri, Balazs Halmos, William R Bodner, et al.
Magnetic Resonance in Medicine|August 12, 2006
Three-dimensional magnetic resonance microscopy of pulmonary solitary tumors in transgenic miceShigeto Kubo, Elena Levantini, Susumu Kobayashi, et al.
Cancer Research|January 26, 2002
Down-regulation and antiproliferative role of C/EBPalpha in lung cancerBalazs Halmos, Claudia S Huettner, Olivier Kocher, et al.
The Oncologist|July 23, 2025
Datopotamab Deruxtecan-Associated Select Adverse Events: Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and ManagementAaron Lisberg, Laura A Huppert, Balazs Halmos, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2025
Randomized Evaluation of the PET-Adjusted IMRT for NSCLC Trial (REPAINT)Nitin Ohri, William R Bodner, Rafi Kabarriti, et al.
Investigational New Drugs|January 15, 2014
Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancerNeelesh Sharma, Nathan Pennell, Myles Nickolich, et al.
Clinical Lung Cancer|April 8, 2026
Impact of Consolidation Durvalumab on Local Control Following Chemoradiotherapy for Non-Small Cell Lung CancerAdel Zakharia, William Bodner, Balazs Halmos, et al.
The Oncologist|April 28, 2020
INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal MalignanciesKhvaramze Shaverdashvili, Elham Azimi-Nekoo, Perry Cohen, et al.
International Journal of Cancer|August 21, 2013
PIAS3 activates the intrinsic apoptotic pathway in non-small cell lung cancer cells independent of p53 statusSnehal Dabir, Amy Kluge, Karen McColl, et al.
Cancers|May 8, 2020
Impact and Diagnostic Gaps of Comprehensive Genomic Profiling in Real-World Clinical PracticeAditi P Singh, Elaine Shum, Lakshmi Rajdev, et al.
Pageof 23